Related Experiment Video
Updated: May 18, 2026

Circumscribed Capsular Infarct Modeling Using a Photothrombotic Technique
Published on: June 2, 2016
Catastrophic antiphospholipid syndrome (CAPS)
Savino Sciascia1, Chary Lopez-Pedrera, Dario Roccatello
1Lupus Research Unit, The Rayne Institute, Division of Women's Health, King's College London, UK. savino.sciascia@unito.it
Catastrophic antiphospholipid syndrome (CAPS) is a rare but life-threatening condition. This review covers the latest understanding of CAPS, including its causes, symptoms, diagnosis, and treatments.
Area of Science:
- Rheumatology
- Internal Medicine
- Pathology
Background:
- Catastrophic antiphospholipid syndrome (CAPS) is a severe variant of antiphospholipid syndrome (APS).
- It involves rapid multiple organ damage, small vessel occlusions, and high-titer antiphospholipid antibodies (aPL).
- CAPS accounts for less than 1% of APS cases but is often fatal.
Purpose of the Study:
- To review current knowledge on the pathogenesis of CAPS.
- To summarize the clinical manifestations and diagnostic criteria for CAPS.
- To discuss contemporary treatment strategies for CAPS.
Main Methods:
- Literature review of pathogenesis, clinical features, diagnosis, and treatment of CAPS.
- Synthesis of existing data on CAPS from various sources.
- Expert consensus on the state-of-the-art in CAPS management.
Main Results:
- CAPS is characterized by acute, widespread thrombotic events affecting multiple organs.
- Diagnosis relies on clinical presentation, histopathology, and serological evidence of aPL.
- Treatment often involves anticoagulation, corticosteroids, and plasma exchange or IVIg.
Conclusions:
- CAPS remains a critical medical emergency requiring prompt diagnosis and aggressive management.
- Further research into pathogenesis may reveal novel therapeutic targets.
- Multidisciplinary care is essential for improving outcomes in CAPS patients.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Pancreatitis II: Pathophysiology
Complement System
Peripheral Artery Disease I: Introduction
Portal Hypertension
Anticoagulant Drugs: Low-Molecular-Weight Heparins

